Totally wrong. The fact that ECT now told us via their hp AND via an official press release that they are free to do whatever they want with CRAM is a sure indication that the injunction is only on SDS from now on and not on CRAM anymore.
If you don't agree with this I will immediately stop talking to you. Your statement in this case is extremely misleading. We clearly heard from the company that from now on CRAM is free and the company didn' state that until the last court decision.
If you believe it or not that is your thing but don't mislead people here with obvious fals statements. CRAM is free to sell, develope, distribute and whatever. I hope you at least admit this otherwise it's senseless to talk to you further.
Market Data 
Markets 
AI
